Trump Administration’s Cuts to Public Health Funding
The upcoming Trump administration aims to cut spending on public health programs. Ironically, one key institution targeted for these cuts is essential for evaluating the cost-effectiveness of healthcare delivery.
The Healthcare Quality and Research Institute, part of the Department of Health and Human Services, is dedicated to helping healthcare providers deliver safe, high-quality, and equitable care.
Despite its role in evaluating cost-effectiveness in healthcare, the Trump administration has proposed a $129 million budget cut, which represents a 25% overall reduction.
Additionally, there’s a projected staffing reduction of 80-90% that has already begun to take place.
These cuts could also impact funding from the National Institutes of Health or recent changes within the Centers for Disease Control and Prevention.
The core competencies of healthcare quality and research institutions focus on three main areas: investing in health system research, developing resources to apply evidence in healthcare practices, and utilizing data to inform healthcare decisions.
Given the reduced workforce, the ability to distribute grants and support preventive care initiatives has been severely limited.
Undermining these institutions poses risks to healthcare quality and research capabilities.
Contrary to the Trump administration’s claims of inefficiency, the agency is unique as it concentrates specifically on the healthcare system and delivery methods, critical for ensuring patient safety.
For instance, questions arise about the impact of government nutrition programs on child health or the effect of state sepsis orders on hospital mortality rates.
These research initiatives aim to shed light on crucial questions influencing healthcare delivery throughout the country.
Moreover, the agency funds doctoral and postdoctoral training programs, preparing a new wave of academics in public health to contribute to significant health-related research.
In total, over $621 million is allocated to health services research and training across the U.S.
This research isn’t just theoretical; it leads to tangible health improvements and saves lives. For example, there has been a 21% reduction in hospital-acquired infections since 2010, with central line infections dropping by 28%, contributing to savings of $28 billion in healthcare costs.
It’s important to recognize the efforts of those in healthcare quality and research programs which may soon face significant challenges under the Trump administration.
An additional function of the agency is to support the U.S. Preventive Services Task Force, an independent group that reviews and recommends preventive care measures such as screenings and vaccinations.
Among these recommendations are recent guidelines for elder abuse screenings, food anxiety, hypertension during pregnancy, and breast cancer.
The agency provides essential staff and scientific reviews to support the task force’s initiatives, collaborating with research organizations to strengthen the evidence base for recommendations.
Under the Affordable Care Act, preventive services backed by strong task force assessments must be covered without charge by Medicare, Medicaid, and private insurers.
Moreover, the Trump administration has sought to dismantle the Preventive Services Task Force, aiming to eliminate the entire panel, even though previous members have advocated for the continuation of the healthcare quality and research institute.
It’s puzzling why effective federal agencies that have saved billions and countless lives are being targeted when they account for a mere 0.02% of the HHS budget.
What might justify such cuts? Perhaps the agency’s operations are seen as another layer of regulation for hospitals and insurance companies, aligning with Trump’s deregulation agenda.
Nevertheless, this perspective overlooks the reality. Through rigorous oversight, healthcare quality and research initiatives have delivered concrete savings and positive outcomes for the healthcare system.
Scaling back this accountability may appeal to deregulation narratives but, in practice, it jeopardizes patient safety, raises costs for Medicare and Medicaid, and ultimately harms public health.
